通过对极地症状的可靠性进行分类来改善慢性咳的顺势疗法处方
Harleen Kaur1, Lex Rutten2, José E Eizayaga3
1Central Council for Research in Homoeopathy, New Delhi, India.
Homeopathy : the journal of the Faculty of Homeopathy
|October 23, 2025
概括
本研究确定了可靠的极性症状 (PS) 与慢性咳的顺势疗法药物相关,使用累积二项式概率 (CBP) 澄清相互矛盾的研究结果并指导治疗选择.
科学领域:
- 顺势疗法研究 顺势疗法研究
- 临床药理学 临床药理学
- 医学中的统计分析.
背景情况:
- 在慢性咳的顺势治疗中,对极性症状 (PS) 的预后因素研究 (PFR) 产生了不一致的结果.
- 数据的统计差异和方法上的局限性导致了这些相互矛盾的结果.
- 与特定的顺势疗法药物相关的PS的可靠识别对于提高治疗疗效至关重要.
研究的目的:
- 系统地识别与用于慢性咳的特定顺势疗法药物相关的统计可靠的极性症状 (PS).
- 通过使用可靠的统计方法,减少预后因素研究的模两可.
- 为了更清楚地了解慢性咳管理中PS和顺势疗法药物选择之间的关系.
主要方法:
- 一项前性观察队列研究,涉及10个门诊中心.
- 慢性咳患者被监测了12个月,结果使用ORIDL仪器,咳严重程度指数和EuroQoL 5D-5L进行评估.
- 计算了PS的患病率和概率比率 (LRs),并使用累积二项概率 (CBP) 来确定与顺势疗法药物具有统计学意义的症状关联.
主要成果:
- 累积双项概率 (CBP) 成功将10种顺势疗法药物中的131种症状归类为"确定的"或"可能的".
- 对于单个药物,确定了特定的症状计数,包括21种阿森尼专辑,23种Bryonia和17种.
- 该方法提供了可靠的PS分类,克服了经典95%置信区间的局限性.
结论:
- 统计变异是极地症状预后因素研究结果冲突的一个关键因素.
- 累积二项概率 (CBP) 提供了一种可靠的方法来分类与顺势疗法药物相关的极性症状.
- 进一步的临床验证和研究方法的从业人员培训是推推进顺势疗法研究.
相关概念视频
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
3.1K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
3.1K
Chronic Obstructive Pulmonary Disease-I: Introduction
3.6K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.6K
COPD: Management Using Bronchodilators and Corticosteroids
722
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
722
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
957
Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
957
Chronic Obstructive Pulmonary Disease
2.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.2K
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
3.5K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
3.5K


